Genenta Science srl:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Genenta Science srl - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10980
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genenta Science srl (Geneta Science) is a biotechnology company that develops gene therapies based on transcriptional and mirRNA-mediated controls. The company develops gene transfer strategy into autologous hematopoietic stem and progenitor cells in order to target interferon-a expression to tumor-infiltrating monocytes and macrophages. Its gene is delivered into the HSPCs using viral vector, Lentivirus. The company’s gene therapy utilizes a combination of transcriptional and microRNA-mediated control that allows tumor-infiltrating monocytes and macrophages to selectively express the tumor area reducing the high toxicity of normally toxic interferon. Geneta Science is headquartered in Milan, Italy.

Genenta Science srl – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genenta Science srl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genenta Science srl, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genenta Science srl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genenta Science srl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genenta Science srl, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Genenta Science srl, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Genenta Science Raises USD8.4 Million in Series B Financing 10
Genenta Science Raises USD11.5 Million in Series A Financing 11
Partnerships 12
Genenta Science and San Raffaele Hospital Enter into Agreement with Amgen 12
MolMed Enters into Co-Development Agreement with Genenta Science 13
Genenta Science srl – Key Competitors 14
Genenta Science srl – Key Employees 15
Genenta Science srl – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Genenta Science srl, Pharmaceuticals & Healthcare, Key Facts 2
Genenta Science srl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genenta Science srl, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genenta Science srl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genenta Science srl, Deals By Therapy Area, 2012 to YTD 2018 8
Genenta Science srl, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Genenta Science Raises USD8.4 Million in Series B Financing 10
Genenta Science Raises USD11.5 Million in Series A Financing 11
Genenta Science and San Raffaele Hospital Enter into Agreement with Amgen 12
MolMed Enters into Co-Development Agreement with Genenta Science 13
Genenta Science srl, Key Competitors 14
Genenta Science srl, Key Employees 15
Genenta Science srl, Other Locations 16

List of Figures
Genenta Science srl, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Genenta Science srl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Genenta Science srl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Genenta Science srl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Genenta Science srl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genenta Science srl, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Genenta Science srl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genenta Science srl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Genenta Science srl:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • W&T Offshore, Inc. (WTI)-石油・ガス分野:企業M&A・提携分析
    Summary W&T Offshore, Inc. (W&T Offshore) is an independent oil and natural gas company. It carries out acquisition, exploitation, development and exploration of oil and natural gas assets both onshore and offshore in the Gulf of Mexico. The company acquires rights to explore and develop new prospec …
  • Sanochemia Pharmazeutika AG (SAC)-製薬・医療分野:企業M&A・提携分析
    Summary Sanochemia Pharmazeutika AG (Sanochemia) is a specialty pharmaceutical company that develops and manufactures of innovative drugs in selected indication areas such as neurodegeneration, pain and cancer, as well as diagnostic products based on contrast media. The company’s product portfolio i …
  • ProMIS Neurosciences Inc (PMN):企業の財務・戦略的SWOT分析
    ProMIS Neurosciences Inc (PMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Coeur Mining, Inc:企業のM&A・事業提携・投資動向
    Coeur Mining, Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Coeur Mining, Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Dana Brevini SpA:企業の戦略・SWOT・財務情報
    Dana Brevini SpA - Strategy, SWOT and Corporate Finance Report Summary Dana Brevini SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Electricite de France (EDF):戦略・SWOT・企業財務分析
    Electricite de France (EDF) - Strategy, SWOT and Corporate Finance Report Summary Electricite de France (EDF) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Enterprise Holdings, Inc.:企業の戦略・SWOT・財務情報
    Enterprise Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Enterprise Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • The Boston Beer Company, Inc.:企業の戦略・SWOT・財務情報
    The Boston Beer Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Boston Beer Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Stifel Financial Corp.:企業のM&A・事業提携・投資動向
    Stifel Financial Corp. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Stifel Financial Corp. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Fifth Third Bancorp:企業のM&A・事業提携・投資動向
    Fifth Third Bancorp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fifth Third Bancorp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • HUGO BOSS AG:企業の戦略・SWOT・財務情報
    HUGO BOSS AG - Strategy, SWOT and Corporate Finance Report Summary HUGO BOSS AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Censo Biotechnologies Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Censo Biotechnologies Ltd (Censo) formerly Roslin Cellab Limited, a subsidiary of Roslin Foundation, is a provider of human cells and contract research services for drug discovery, toxicity testing and cell banking. The company offers iPSC services; differentiated cell types; in vitro assays …
  • Maruha Nichiro Corporation
    Maruha Nichiro Corporation - Strategy, SWOT and Corporate Finance Report Summary Maruha Nichiro Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Nacco Industries Inc:企業の戦略・SWOT・財務情報
    Nacco Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Nacco Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Veridian Corporation:発電所・企業SWOT分析
    Veridian Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Cebu Air Inc:企業の戦略・SWOT・財務情報
    Cebu Air Inc - Strategy, SWOT and Corporate Finance Report Summary Cebu Air Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • SMA Solar Technology AG (S92):電力:M&Aディール及び事業提携情報
    Summary SMA Solar Technology AG (SMA) is a renewable energy company. It develops, produces, and distributes photovoltaic inverters, choke coils, transformers, and monitoring and energy management systems for PV systems. The company also offers intelligent energy management solutions and digital serv …
  • CK Hutchison Holdings Ltd:企業の戦略・SWOT・財務情報
    CK Hutchison Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary CK Hutchison Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Aveda Transportation and Energy Services Inc (AVE):石油・ガス:M&Aディール及び事業提携情報
    Summary Aveda Transportation and Energy Services Inc (Aveda), formerly Phoenix Oilfield Hauling Inc is an oilfield service provider that offers energy transportation and other energy related services. The company provides specialized transportation services and equipment for drilling, exploration, d …
  • RedHill Biopharma Ltd (RDHL):製薬・医療:M&Aディール及び事業提携情報
    Summary RedHill Biopharma Ltd (RedHill) is a biopharmaceutical company that develops and commercializes therapeutics in the areas of gastroenterology (GI) and cancer. The company’s commercial product portfolio consists of Donnatal for IBS and acute enterocolitis; Esomeprazole Strontium Delayed-Relea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆